Qiling Tiaoyuan Decoction

Qiling Tiaoyuan Decoction is a Traditional Chinese Medicine (TCM) herbal formula developed by Yueyang Hospital of Integrated Traditional Chinese and Western Medicine, affiliated with the Shanghai University of TCM. It is specifically formulated for the treatment of advanced gastric cancer, particularly in patients classified under the TCM syndrome of deficiency of the middle jiao and qi stagnation. The decoction is typically used as an adjuvant therapy in combination with standard chemotherapy regimens, such as XELOX (oxaliplatin and capecitabine). Its therapeutic objectives include tonifying the spleen, replenishing qi, and regulating the middle jiao to improve patient quality of life, mitigate chemotherapy-induced side effects, and potentially enhance the overall anti-tumor response in stage IV gastric cancer patients.

Other names

芪苓调元汤